Monsanto Company (MON) Shares Sold by Accident Compensation Corp

Accident Compensation Corp reduced its stake in Monsanto Company (NYSE:MON) by 20.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,500 shares of the basic materials company’s stock after selling 4,800 shares during the period. Accident Compensation Corp’s holdings in Monsanto were worth $2,217,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Puplava Financial Services Inc. increased its holdings in shares of Monsanto by 0.4% in the 2nd quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock valued at $251,000 after purchasing an additional 9 shares in the last quarter. Enterprise Financial Services Corp grew its holdings in shares of Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after acquiring an additional 16 shares in the last quarter. Forward Management LLC grew its holdings in shares of Monsanto by 0.5% in the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock valued at $379,000 after acquiring an additional 16 shares in the last quarter. Lee Financial Co grew its holdings in shares of Monsanto by 0.3% in the second quarter. Lee Financial Co now owns 6,067 shares of the basic materials company’s stock valued at $718,000 after acquiring an additional 17 shares in the last quarter. Finally, Savant Capital LLC grew its holdings in shares of Monsanto by 0.6% in the second quarter. Savant Capital LLC now owns 3,102 shares of the basic materials company’s stock valued at $367,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at $10,255,243.17. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is owned by corporate insiders.

Shares of Monsanto Company (MON) traded up $0.03 during midday trading on Wednesday, reaching $118.29. The company’s stock had a trading volume of 621,897 shares, compared to its average volume of 1,962,239. Monsanto Company has a 1-year low of $104.08 and a 1-year high of $122.79. The company has a market capitalization of $52,212.13, a price-to-earnings ratio of 21.45, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.51 billion. During the same period in the prior year, the company earned $0.07 earnings per share. Monsanto’s revenue was up 4.8% compared to the same quarter last year. equities research analysts anticipate that Monsanto Company will post 5.74 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.83%. The ex-dividend date is Thursday, January 4th. Monsanto’s dividend payout ratio (DPR) is 42.27%.

Several equities analysts have recently issued reports on the company. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a report on Thursday, September 14th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $128.00 target price on shares of Monsanto in a report on Wednesday, November 15th. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 target price on shares of Monsanto in a report on Friday, September 1st. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $128.00 target price on shares of Monsanto in a report on Friday, September 15th. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Monsanto has an average rating of “Hold” and a consensus price target of $124.61.

ILLEGAL ACTIVITY WARNING: “Monsanto Company (MON) Shares Sold by Accident Compensation Corp” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://stocknewstimes.com/2017/12/06/monsanto-company-mon-shares-sold-by-accident-compensation-corp.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply